BioCatalyst

BNT162b2 (2025/2026 formulation) — catalyst calendar

1 verified catalyst event(s) referencing BNT162b2 (2025/2026 formulation), each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-07-31
in 1mo
ESTIMATED
 READOUT
A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in C
Phase 3 · COVID-19, SARS-COV-2 Infection
 BNTX BioNTech SE BNT162b2 (2025/2026 formulation) ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.